FMR LLC 13D and 13G filings for Kymera Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-12 10:32 am Purchase | 2024-11-08 | 13G | Kymera Therapeutics, Inc. KYMR | FMR LLC | 5,109,141 7.933% | 2,761,614 (+117.64%) | Filing |
| 2022-02-09 09:22 am Sale | 2022-02-08 | 13G | Kymera Therapeutics, Inc. KYMR | FMR LLC | 2,347,527 4.568% | -94,533 (-3.87%) | Filing |
| 2021-02-08 10:27 am Purchase | 2021-02-05 | 13G | Kymera Therapeutics, Inc. KYMR | FMR LLC | 2,442,060 5.492% | 2,442,060 (New Position) | Filing |